Gao Hanlin's Form 4 filing
Fulgent Genetics, Inc. (FLGT) · filed May 28, 2025
- Accession no.
- 0000950170-25-078346
- Filed
- May 28, 2025
- Trade date
- May 27, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $21.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gao HanlinCIK 0001684532 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Common Stock | SSaleDisposed | −383 | $20.58 | −$7,882.14 | 962,691 | Direct | |
| May 27, 2025 | Common Stock | SSaleDisposed | −656 | $20.52 | −$13,461.12 | 962,035 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.